EUVIMEDEUVIMED entdecken
Crossref

1408 Aortic Tissue Valve Replacement in Young Patients

X Y Ng, R Karsan, G Beattie

British Journal of Surgery · 10.07.2026 · 113 (Supplement_6)

DOI: 10.1093/bjs/znag063.322 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 10.07.2026. Verfasst von X Y Ng und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To assess the incidence of reoperation, time to failure since replacement of the tissue valve. Evaluate the influence of comorbidities on outcomes. The long-term survival of patients aged 40-60 who undergo isolated aortic bioprosthetic valve replacement.

Method

The regional cardiac surgery database was interrogated and all isolated aortic valve replacements identified from 2008 to 2024, between the age of 40-60, at the time of operation. Patient’s demographic, comorbidities, previous surgeries, and medical history were identified from the regional database and the electronic care record. When available the most op to date echocardiogram was found.

Results

735 patients had an isolated aortic valve replacement, and 211 patients underwent aortic tissue valve replacement. Of the 211 patients, 8 (3.8%) required a second aortic valve replacement after a median follow-up period of 38 months. The most common reason for reoperation was aortic stenosis and endocarditis. Diabetes is one of the comorbidities associated with an increased risk of reoperation. A total of 18 patients in this study have died, in which 5 of them were females and 13 of them are males. Early practice was dominated by the Edwards Perimount Magna bioprosthesis, whose use declined after 2018 in parallel with the rapid adoption of the Edwards Inspiris Resilia valve, which accounted for the majority of implants by 2024.

Conclusions

Aortic tissue valve replacement in patients aged 40-60 demonstrates favorable long-term survival rates. Comorbidities such as diabetes increase the risk of early valve degeneration. Further studies are needed to explore strategies to improve valve longevity and better manage patients with multiple comorbidities.

Zitieren

APA

Ng, X. Y., Karsan, R., & Beattie, G. (2026). 1408 Aortic Tissue Valve Replacement in Young Patients. British Journal of Surgery, 113(Supplement_6). https://doi.org/10.1093/bjs/znag063.322

Vancouver

Ng XY, Karsan R, Beattie G. 1408 Aortic Tissue Valve Replacement in Young Patients. British Journal of Surgery. 2026;113(Supplement_6). doi:10.1093/bjs/znag063.322

BibTeX
@article{Ng2026,
  author = {Ng, X Y and Karsan, R and Beattie, G},
  title = {1408 Aortic Tissue Valve Replacement in Young Patients},
  journal = {British Journal of Surgery},
  year = {2026},
  volume = {113},
  number = {Supplement_6},
  doi = {10.1093/bjs/znag063.322}
}
Kostenlos starten →